About the Authors
- Nicole A. Datson
-
* E-mail: nicole.datson@bmrn.com
Affiliation BioMarin Nederland BV, Leiden, The Netherlands
- Anchel González-Barriga
-
Affiliation BioMarin Nederland BV, Leiden, The Netherlands
- Eleni Kourkouta
-
Affiliation BioMarin Nederland BV, Leiden, The Netherlands
- Rudie Weij
-
Affiliation BioMarin Nederland BV, Leiden, The Netherlands
- Jeroen van de Giessen
-
Affiliation BioMarin Nederland BV, Leiden, The Netherlands
- Susan Mulders
-
Affiliation BioMarin Nederland BV, Leiden, The Netherlands
- Outi Kontkanen
-
Affiliation Charles River Discovery Research Services, Kuopio, Finland
- Taneli Heikkinen
-
Affiliation Charles River Discovery Research Services, Kuopio, Finland
- Kimmo Lehtimäki
-
Affiliation Charles River Discovery Research Services, Kuopio, Finland
- Judith C. T. van Deutekom
-
Affiliation BioMarin Nederland BV, Leiden, The Netherlands
Competing Interests
NAD, AG-B, EK, RW, JvdG, SM and JCTvD are (former) employees of BioMarin Nederland BV (formerly Prosensa Therapeutics BV) that sponsored this study. SM is inventor on related patent WO2013/162363. OK, TH and KL are employees of Charles River Research Discovery Services in Finland and have no financial conflict of interest related to the submitted manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: NAD JCTvD OK TH. Formal analysis: JvdG SM AG-B RW EK KL TH NAD. Funding acquisition: NAD JCTvD. Investigation: JvdG SM AG-B RW EK KL TH. Methodology: JvdG SM AG-B RW EK KL TH. Project administration: NAD JCTvD. Supervision: NAD. Validation: JvdG SM AG-B RW EK KL TH. Visualization: EK NAD. Writing – original draft: NAD JCTvD. Writing – review & editing: NAD JCTvD AG-B.